Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Eye, Ear & Vision

Quintessence of currently approved and upcoming treatments for dry eye disease

The pathophysiology of DED is complex and multifactorial; there is a need to understand it even deeper. The new treatments and different delivery systems seem promising and provide a hope of effective treatment for DED.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors reviewed FDA-approved and upcoming treatments for dry eye disease using PubMed, the FDA website, ClinicalTrials.gov and public data. They describe several approved drug formulations and devices, plus many newer agents still under evaluation. The authors state that new treatments and delivery systems seem promising, while noting that the disease's pathophysiology needs further understanding.

Who or what was studied
unclear
Limits stated in the abstract
The abstract does not report the number of studies reviewed or the strength of evidence for the newer treatments.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Dry eye. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Eye, Ear & Vision

Comparison of the efficacy of intense pulsed light, 0.05% cyclosporine A eye drops, and 3% diquafosol sodium eye drops in the treatment of moderate to severe dry eye: A prospective cohort study

IPL, 0.05% CsA, and 3% DQS eye drops are effective in treating moderate to severe dry eye. Notably, IPL shows significant advantages over CsA and DQS, owing to its noninvasive nature, effective clearance of meibomian gland obstruction, and marked improvement in tear film quality.

Trial · December 5, 2025 · Lu Y et al.